BackAlnylam Pharmaceuticals Overview

Alnylam Pharmaceuticals Operating Income

Operating Income for ALNY.

Quarterly Operating Income

$268.64M
↑ 1386.07% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$752.14M
↓ 751.92% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin